Authors : Dr. Umme Aman Saba

Volume/Issue : Volume 11 - 2026, Issue 1 - January

Google Scholar : https://tinyurl.com/masuuh4a

Scribd : https://tinyurl.com/fv426t8s

DOI : https://doi.org/10.38124/ijisrt/26jan1458

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Perimenopause is a dynamic transitional phase in a woman’s reproductive life characterized by progressive ovarian aging and fluctuating endocrine activity. Alterations in menstrual pattern are among the earliest and most frequent manifestations of this transition and constitute a major cause of gynecological consultation in midlife women. Clinical interpretation of perimenopausal bleeding is challenging becausee physiological cycle variability may coexist with structural uterine pathology or premalignant and malignant endometrial conditions. This narrative review synthesizes evidence on the epidemiology, biological mechanisms, clinical patterns, diagnostic approach, and management of perimenopausal menstrual irregularities. Emphasis is placed on individualized assessment using the FIGO PALM-COEIN framework and stepwise management strategies supported by international and national guidelines. A balanced approach is essential to provide symptom relief while ensuring timely detection of serious underlying pathology.

Keywords : Perimenopause; Abnormal Uterine Bleeding; Heavy Menstrual Bleeding; PALM-COEIN; Menopausal Transition.

References :

1. Harlow SD, et al. Menstrual cycle changes during the menopausal transition. Menopause. 2000;7:355–364.
2. Harlow SD, et al. Executive summary of the Stages of Reproductive Aging Workshop +10. Menopause. 2012;19:387–395.
3. Gold EB, et al. Factors associated with age at natural menopause. Am J Epidemiol. 2001;153:865–874.
4. Santoro N, et al. Characterization of reproductive hormonal dynamics in perimenopause. J Clin Endocrinol Metab. 1996;81:1495–1501.
5. Fraser IS, et al. Estimating menstrual blood loss. Obstet Gynecol. 1984;64:782–788.
6. Munro MG, et al. Ovulatory dysfunction and abnormal uterine bleeding. Obstet Gynecol Clin North Am. 2015;42:595–613.
7. Gupta J, et al. Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med. 2013;368:128–137.
8. Kaunitz AM, et al. Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding. Obstet Gynecol. 2010;116:625–632.
9. Clark TJ, et al. Accuracy of hysteroscopy in diagnosis of endometrial pathology. BMJ. 2002;325:1–5.
10. Dreisler E, et al. Diagnostic accuracy of endometrial sampling. Acta Obstet Gynecol Scand. 2009;88:103–110.
11. Epstein E, et al. Transvaginal sonography in perimenopausal bleeding. Ultrasound Obstet Gynecol. 2001;18:157–162.
12. Vercellini P, et al. Adenomyosis: epidemiological factors and clinical phenotype. Hum Reprod. 2014;29:139–147.
13. Bulun SE. Uterine fibroids. N Engl J Med. 2013;369:1344–1355.
14. Munro MG, et al. Abnormal uterine bleeding and underlying pathophysiology. Int J Gynaecol Obstet. 2018;143:3–13.
15. Hapangama DK, et al. Endometrial hemostasis in heavy menstrual bleeding. Hum Reprod Update. 2016;22:80–94.
16. Chen BA, et al. Bleeding patterns with levonorgestrel intrauterine system. Am J Obstet Gynecol. 2020;222:512.e1–512.e10.
17. Lethaby A, et al. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev. 2013.
18. Lethaby A, et al. Tranexamic acid for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019;CD000249.
19. Bromberger JT, et al. Mood symptoms during the menopausal transition. JAMA Psychiatry. 2010;67:1000–1008.
20. El Khoudary SR, et al. The menopause transition and women’s health. J Clin Endocrinol Metab. 2019;104:3985–4003.
21. SWAN Investigators. Longitudinal changes in menstrual cycle characteristics. Menopause. 2011;18:423–430.
22. Dueholm M, et al. Imaging techniques for abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2017;40:23–43.
23. Farquhar C, et al. Surgical versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2017.
24. Critchley HOD, et al. Mechanisms of abnormal uterine bleeding. Reprod Sci. 2020;27:1890–1902.
25. Fraser IS. Heavy menstrual bleeding: modern management. Best Pract Res Clin Obstet Gynaecol. 2017;40:62–72.
26. Dreisler E, et al. Perimenopausal abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2022;81:14–27.
27. Santoro N, et al. Perimenopause and hormonal changes. Endocrinol Metab Clin North Am. 2015;44:495–512.
28. Munro MG. Abnormal uterine bleeding in midlife women. Climacteric. 2018;21:1–7.
29. Hickey M, et al. Bleeding disorders in perimenopause. Lancet. 2012;379:2103–2111.
30. Berek JS, Novak E. Berek & Novak’s Gynecology. 16th ed. Philadelphia: Wolters Kluwer; 2020.
31. Lobo RA, et al. Treatment of the Postmenopausal Woman. 4th ed. London: Academic Press; 2014.
32. Hoffman BL, et al. Williams Gynecology. 4th ed. New York: McGraw-Hill; 2020.
33. Shaw RW, et al. Shaw’s Textbook of Gynecology. 17th ed. New Delhi: Elsevier India; 2021.
34. National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management. NICE guideline NG88. London: NICE; 2018.
35. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 128: Diagnosis of abnormal uterine bleeding. Obstet Gynecol. 2012;120:197–206.
36. Munro MG, et al. FIGO recommendations on abnormal uterine bleeding terminology and management. Int J Gynaecol Obstet. 2018;143:3–13.